Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy.
Cellerix is leading the development of a new generation of treatments using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials Phase I and II have been very promising.
Meet us at...
-
European Stem Cells & Regenerative Medicine Congress 2008 - London, UK - 13th to 15th May 2008
-
DDW - San Diego, USA - 18th to 21th May 2008
- see more events.